Dashboard
Manage Tickers

CTLT Catalent, Inc.

NYSE catalent.com


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 63.48
-- x --
-- x --
-- - --
$ 41.15 - $ 63.50
13,882,060
na
11.52B
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2024 09-30-2024 10-Q
2 09-06-2024 06-30-2024 10-K
3 05-08-2024 03-31-2024 10-Q
4 02-14-2024 12-31-2023 10-Q
5 12-08-2023 06-30-2023 10-K
6 12-08-2023 09-30-2023 10-Q
7 06-12-2023 03-31-2023 10-Q
8 02-07-2023 12-31-2022 10-Q
9 11-01-2022 09-30-2022 10-Q
10 08-29-2022 06-30-2022 10-K
11 05-03-2022 03-31-2022 10-Q
12 02-01-2022 12-31-2021 10-Q
13 11-02-2021 09-30-2021 10-Q
14 08-30-2021 06-30-2021 10-K
15 05-04-2021 03-31-2021 10-Q
16 02-02-2021 12-31-2020 10-Q
17 11-03-2020 09-30-2020 10-Q
18 08-31-2020 06-30-2020 10-K
19 05-05-2020 03-31-2020 10-Q
20 02-03-2020 12-31-2019 10-Q
21 11-05-2019 09-30-2019 10-Q
22 08-27-2019 06-30-2019 10-K
23 05-07-2019 03-31-2019 10-Q
24 02-05-2019 12-31-2018 10-Q
25 11-06-2018 09-30-2018 10-Q
26 08-28-2018 06-30-2018 10-K
27 05-01-2018 03-31-2018 10-Q
28 02-05-2018 12-31-2017 10-Q
29 11-06-2017 09-30-2017 10-Q
30 08-28-2017 06-30-2017 10-K
31 05-04-2017 03-31-2017 10-Q
32 02-06-2017 12-31-2016 10-Q
33 11-07-2016 09-30-2016 10-Q
34 08-29-2016 06-30-2016 10-K
35 05-04-2016 03-31-2016 10-Q
36 02-09-2016 12-31-2015 10-Q
37 11-03-2015 09-30-2015 10-Q
38 09-02-2015 06-30-2015 10-K
39 05-05-2015 03-31-2015 10-Q
40 02-12-2015 12-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fda-flags-alarming-contamination-at-novo-nordisk-indiana-plant-including-cat-hair-bacteria-and-foreign-particles
FDA Flags Alarming Contamination At Novo N...
08/25/2025 17:59:39

Novo Nordisk's acquired facility faces scrutiny over recurring contamination, incomplete investigations, and ineffective co...

Core News & Articles
Lennox To Replace Catalent In S&P 500, Eff...
12/18/2024 22:29:19

ozempic-maker-novo-nordisk-invests-over-1-billion-in-new-denmark-production-facility-closer-to-add-3-more-from-catalent
Ozempic Maker Novo Nordisk Invests Over $1...
12/16/2024 13:32:08

Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and opera...

Core News & Articles
EU Regulators Say Novo Holdings Secures Un...
12/06/2024 18:06:00

- Reuters

Core News & Articles
EU Antitrust Regulators Expected to Approv...
11/22/2024 17:43:18

- Reuters 

catalent-q1-2025-adj-eps-013-may-not-be-comparable-to-005-estimate-sales-102b-miss-106b-estimate
Catalent Q1 2025 Adj EPS $(0.13) May Not B...
11/05/2024 12:03:43

Catalent (NYSE:CTLT) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.05 by 360...

roches-q3-sales-surge-led-by-ocrevus-vabysmo-urges-regulators-to-block-novo-holdings-165b-catalent-acquisition
Roche's Q3 Sales Surge Led By Ocrevus, Vab...
10/23/2024 23:05:27

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised c...

catalents-ceo-confirms-leadership-continuity-as-novo-holdings-acquisition-nears
Catalent's CEO Confirms Leadership Continu...
10/21/2024 11:03:09

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, toda...

after-us-senator-unions-urge-federal-trade-commission-to-block-novos-165b-acquisition-of-catalent
After US Senator, Unions Urge Federal Trad...
10/18/2024 18:39:32

Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns ov...

jim-cramer-we-need-more-uranium-recommends-this-stock-says-novo-nordisk-doesnt-hold-a-candle-to-big-pharma-rival
Jim Cramer: 'We Need More Uranium,' Recomm...
10/15/2024 12:22:07

Jim Cramer believes Uranium Energy Corp. is going higher, thanks to a recent acquisition deal. Novo Nordisk faces antitrust con...

catalent-agrees-to-sell-its-oral-solids-development-and-small-scale-manufacturing-facility-in-somerset-nj-financial-details-not-disclosed
Catalent Agrees To Sell Its Oral Solids De...
10/14/2024 10:02:10

ftc-faces-pressure-to-block-novo-nordisk-catalent-merger-over-antitrust-fears
FTC Faces Pressure to Block Novo Nordisk-C...
10/10/2024 17:12:25

Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

Core News & Articles
'Warren urges FTC to probe deal that would...
10/10/2024 13:32:58

https://www.statnews.com/pharmalot/2024/10/10/novo-eli-lilly-obesity-weight-diabetes-warren-ftc-antitrust/ U.S. Sen. Elizabeth ...

baird-downgrades-catalent-to-neutral-maintains-price-target-to-635
Baird Downgrades Catalent to Neutral, Main...
09/24/2024 10:41:53

Baird analyst Eric Coldwell downgrades Catalent (NYSE:CTLT) from Outperform to Neutral and maintains the price target from $...

william-blair-reiterates-market-perform-on-catalent
William Blair Reiterates Market Perform on...
09/03/2024 14:54:20

William Blair analyst Max Smock reiterates Catalent (NYSE:CTLT) with a Market Perform.

catalent-q4-2024-adj-eps-065-beats-047-estimate-sales-1301b-beat-1224b-estimate
Catalent Q4 2024 Adj. EPS $0.65 Beats $0.4...
08/29/2024 11:45:10

Core News & Articles
Lilly Executive Says Concord Manufacturing...
08/08/2024 14:52:15

Conference Call

Core News & Articles
Novo Nordisk CFO Said In Active Dialogue W...
08/07/2024 11:41:07

catalent-completes-25m-upgrade-to-schorndorf-site-featuring-expanded-storage-and-new-fastchain-area
Catalent Completes $25M Upgrade To Schornd...
07/16/2024 06:29:42

The expansion increases the site's footprint by 32,000 square feet (3,000 square meters), adding storage and handling of cl...

rbc-capital-reiterates-sector-perform-on-catalent-maintains-635-price-target
RBC Capital Reiterates Sector Perform on C...
07/11/2024 15:00:20

RBC Capital analyst Sean Dodge reiterates Catalent (NYSE:CTLT) with a Sector Perform and maintains $63.5 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION